MATRIX platform to analyze translation machinery remodeling in glioblastoma cells

STAR Protoc. 2022 Dec 16;3(4):101919. doi: 10.1016/j.xpro.2022.101919. Epub 2022 Dec 9.

Abstract

Here, we present a protocol using MATRIX (mass spectrometry analysis of active translation factors using ribosome density fractionation and isotopic labeling experiments) platform to investigate changes of the protein synthesis machinery in U87MG glioblastoma cells in response to the rocaglate silvestrol. This protocol describes steps to perform SILAC (stable isotope labeling by amino acids in cell culture), ribosome density fractionation, protein isolation, and mass spectrometry analysis. This approach can be applied to study any adaptive remodeling of protein synthesis machineries. For complete details on the use and execution of this protocol, please refer to Ho et al. (2021).1.

Keywords: Cancer; Mass Spectrometry; Protein Biochemistry; Proteomics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acids / metabolism
  • Glioblastoma*
  • Humans
  • Mass Spectrometry / methods
  • Proteins / chemistry
  • Proteomics / methods

Substances

  • Proteins
  • Amino Acids